We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Phase 2A Study of GM 608 in Mild to Moderate Parkinson Disease (GAP-PD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01850381
Recruitment Status : Completed
First Posted : May 9, 2013
Last Update Posted : August 8, 2019
Columbia University
Information provided by (Responsible Party):
Genervon Biopharmaceuticals, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2014
Actual Study Completion Date : July 2014
Certification/Extension First Submitted : August 1, 2017